Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration. Intracoronary (IC) bolus application of abciximab causes very high...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wolters Kluwer Medknow Publications 2013-01-01
Cyfres:	Heart Views
Pynciau:	Abciximab acute coronary artery disease intracoronary intravenous stent thrombosis tirofiban
Mynediad Ar-lein:	http://www.heartviews.org/article.asp?issn=1995-705X;year=2013;volume=14;issue=2;spage=62;epage=67;aulast=Balghith
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!